KSE - Delayed Quote KRW
Lotte Chemical Corporation (011170.KS)
60,100.00
-200.00
(-0.33%)
At close: May 2 at 3:30:28 PM GMT+9
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
20,430,375,565.35
20,430,375,565.35
19,946,396,629.90
22,276,082,763.69
18,120,462,422.75
Cost of Revenue
20,100,524,805.35
20,100,524,805.35
19,165,102,990.63
21,992,795,753.19
15,656,512,541.62
Gross Profit
329,850,760
329,850,760
781,293,639.27
283,287,010.50
2,463,949,881.13
Operating Expense
1,212,337,483
1,212,337,483
1,128,996,139
1,045,893,994
928,308,992
Operating Income
-882,486,723
-882,486,723
-347,702,499.73
-762,606,983.50
1,535,640,889.13
Net Non Operating Interest Income Expense
-227,821,960.80
-227,821,960.80
-154,264,681.25
-49,449,966.49
-27,437,723.15
Pretax Income
-2,258,149,346.04
-2,258,149,346.04
-452,271,274.08
-392,619,240.01
1,887,483,719.88
Tax Provision
-432,593,593.90
-432,593,593.90
-413,028,188.83
-420,439,696.97
473,835,630.66
Net Income Common Stockholders
-1,710,507,345.75
-1,710,507,345.75
-50,043,098.36
61,593,615.42
1,333,701,079.29
Basic EPS
-40.56k
--
-1.20k
1.80k
37.32k
Diluted EPS
-40.56k
--
-1.20k
1.80k
37.32k
Basic Average Shares
42,167.07
--
41,737.36
34,180.70
35,737.59
Diluted Average Shares
42,167.07
--
41,737.36
34,180.70
35,737.59
Total Operating Income as Reported
-894,081,004.42
-894,081,004.42
-347,702,499.47
-762,606,983.91
1,535,640,888.89
Rent Expense Supplemental
17,731,372
17,731,372
15,691,268
17,951,530
12,595,371
Total Expenses
21,312,862,288.35
21,312,862,288.35
20,294,099,129.63
23,038,689,747.19
16,584,821,533.62
Net Income from Continuing & Discontinued Operation
-1,710,507,345.75
-1,710,507,345.75
-50,043,098.36
61,593,615.42
1,333,701,079.29
Normalized Income
-786,250,297.59
-786,250,297.59
-48,361,835.48
476,169,583.55
1,346,804,911.72
Interest Income
180,060,079
180,060,079
205,827,912
75,196,180
31,582,805
Interest Expense
421,255,356
421,255,356
378,887,652
149,890,258
85,170,533
Net Interest Income
-227,821,960.80
-227,821,960.80
-154,264,681.25
-49,449,966.49
-27,437,723.15
EBIT
-1,836,893,990.04
-1,836,893,990.04
-73,383,622.08
-242,728,982.01
1,972,654,252.88
EBITDA
-546,215,154.04
-546,215,154.04
1,099,202,113.92
705,188,476.99
2,805,390,193.15
Reconciled Cost of Revenue
20,100,524,805.35
20,100,524,805.35
19,165,102,990.63
21,992,795,753.19
15,656,512,541.62
Reconciled Depreciation
1,290,678,836
1,290,678,836
1,172,585,736
947,917,459
832,735,940.27
Net Income from Continuing Operation Net Minority Interest
-1,710,507,345.75
-1,710,507,345.75
-50,043,098.36
61,593,615.42
1,333,701,079.29
Total Unusual Items Excluding Goodwill
-1,143,274,012
-1,143,274,012
-2,212,188
-111,542,025
-17,496,059
Total Unusual Items
-1,143,274,012
-1,143,274,012
-2,212,188
222,165,975
-17,496,059
Normalized EBITDA
597,058,857.96
597,058,857.96
1,101,414,301.92
483,022,501.99
2,822,886,252.15
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-219,016,963.84
-219,016,963.84
-530,925.12
-30,674,056.88
-4,392,226.57
12/31/2021 - 1/4/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade